Search
Innate Pharma SA
IPHAAdd to Watchlist
1.480USD
-0.040-2.63%
Close 10-07 16:00（ET）
165.32MMarket Cap
LossP/E TTM
IPHA Financials
See Innate Pharma SA's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.
Key Financial Ratios
Market Cap
165.32M
Dividend TTM
0.00
P/E TTM
-2.53
EPS TTM
-0.59
Revenue
3.21M
Net Profit
-49.47M
ROE
-162.91%
ROA
-33.51%
Innate Pharma SA Earnings Date
Latest Release
Sep 17, 2026
EPS / Forecast
--/--
Revenue / Forecast
590.91K/--
Financial Statement Highlights
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FAQs
What is the total revenue of Innate Pharma SA?
According to Innate Pharma SA's FY2025 earnings report, its total revenue reached 3.21M, with a year-on-year change of 13.63M.
What are the current assets of Innate Pharma SA?
According to Innate Pharma SA's FY2025 earnings report, its current assets were 53.84M, with a year-on-year change of -41.87.
What are the total assets of Innate Pharma SA?
According to Innate Pharma SA's FY2025 earnings report, its total assets of Innate Pharma SA were 72.29M, with a year-on-year change of -39.74.
What are the total liabilities of Innate Pharma SA?
According to Innate Pharma SA's FY2025 earnings report, its total liabilities of Innate Pharma SA were 97.31M, with a year-on-year change of -11.87.
What is the total equity of Innate Pharma SA?
According to Innate Pharma SA's FY2025 earnings report, its total equity of Innate Pharma SA was -25.02M, with a year-on-year change of -362.18.
What is the net operating income of Innate Pharma SA?
According to Innate Pharma SA's FY2025 earnings report, its net operating income of Innate Pharma SA was -58.92M, with a year-on-year change of -5.77.
What is the net investment of Innate Pharma SA?
According to Innate Pharma SA's FY2025 earnings report, its net investment of Innate Pharma SA was 8.40M, with a year-on-year change of -15.45.
What is the net financing of Innate Pharma SA?
According to Innate Pharma SA's FY2025 earnings report, its net financing of Innate Pharma SA was 7.00M, with a year-on-year change of 207.81.
What is the Earnings Per Share (EPS) of Innate Pharma SA?
According to Innate Pharma SA's FY2025 earnings report, its Earnings Per Share (EPS) was -0.64, with a year-on-year change of -2.02.
What is the net income of Innate Pharma SA?
According to Innate Pharma SA's FY2025 earnings report, its net income was -56.68M, with a year-on-year change of -6.08.
What is the net margin of Innate Pharma SA?
According to Innate Pharma SA's FY2025 earnings report, its net profit margin was -1764.51, with a year-on-year change of -350.20.
What is the gross margin of Innate Pharma SA?
According to Innate Pharma SA's FY2025 earnings report, its gross margin was 1.29, with a year-on-year change of -98.30.
What is the debt-to-asset ratio of Innate Pharma SA?
According to Innate Pharma SA's FY2025 earnings report, its debt-to-asset ratio was 35.99, with a year-on-year change of 28.96.
What is the Return on Assets (ROA) of Innate Pharma SA?
According to Innate Pharma SA's FY2025 earnings report, its Return on Assets (ROA) was -56.60, with a year-on-year change of -68.89.
What is the operating profit of Innate Pharma SA?
According to Innate Pharma SA's FY2025 earnings report, its operating profit was -58.92M, with a year-on-year change of -5.77.